Company
C4 Therapeutics, Inc. (CCCC)
Standardized SEC financial data for C4 Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001662579 · NASDAQ · Biological Products, (No Diagnostic Substances).
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $45.8M | $31.1M | $20.8M | $35.6M | $35.9M |
| R&D expense | $78.4M | $94.7M | $117.8M | $117.7M | $110.6M | $104.2M |
| SG&A expense | $15.2M | $33.3M |
Standardized from C4 Therapeutics, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$67.2M | -$87.0M | -$105.9M | -$106.8M | -$65.2M | -$98.7M |
| Capital expenditures |
Get CCCC data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CCCC/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CCCC/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"